Pulmonaryhypertensionnews.com59m
Adempas helps lower risk in PAH patients, newer risk model confirms
A possibly more precise risk model showed Adempas helped PAH patients at intermediate risk of death arrive at more favorable ...
The American Journal of Managed Care19d
Pulmonary Arterial Hypertension
Many roadblocks exist to detecting and assessing pulmonary hypertension (PH) in patients with interstitial lung disease (ILD), but creative thinking and artificial intelligence (AI) may soon help ...
pulmonologyadvisor5d
Exercise Pulmonary Hypertension Independently Predicts Survival in Some Patients
Exercise PH — measured by the mPAP/CO slope — may predict survival in patients with normal or mildly elevated pulmonary arterial pressure.
The New England Journal of Medicine16d
Effects of Mitral-Valve Replacement on the Pulmonary Vascular Dynamics of Patients with Pulmonary Hypertension
14 The pulmonary hypertension associated with mitral-valve ... pressure gradient was associated with an elevation of pulmonary blood flow. As a consequence, the calculated pulmonary vascular ...
Pulmonaryhypertensionnews.com12d
Phase 2 trial of tiprelestat for PAH receives FDA advice
The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial ...
Hosted on MSN19d
UK MHRA approves MSD’s pulmonary arterial hypertension therapy
Designed to address the underlying causes of PAH, which involves high blood pressure in the pulmonary arteries ... "UK MHRA approves MSD’s pulmonary arterial hypertension therapy" was originally ...